Development and validation of a quality of life instrument for patients with liver cancer QOL-LC

15Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To develop a self-administered quality of life instrument for patients with liver cancer. Methods: The programmed decision procedure, the theory and methodology in developing rating scale were used to establish the instrument. On the basis of the data from 105 liver cancer patients, the psychometric properties of the scale were evaluated by indicators of validity, reliability coefficients, and statistical methods like structural equation modeling. Results: The test-retest coefficients for physical, psychological, symptom/side effects, social domains, and the overall scale are 0.76, 0.86, 0.71, 0.80, and 0.84, respectively. The α coefficients for the above 4 domains are 0.78, 0.81, 0.75, and 0.68, respectively. The correlation analysis and the structural equation model showed good construct validity. The criterion-related was confirmed by using the functional living index-cancer simultaneously. The scale can reflect the changes of patients' quality of life after treatment. Conclusions: The instrument is of good validity, reliability, and responsiveness and has been broadly used in China. Copyright © 2010 by Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Wan, C., Fang, J., Yang, Z., Zhang, C., Luo, J., Meng, Q., & Jiang, D. (2010). Development and validation of a quality of life instrument for patients with liver cancer QOL-LC. American Journal of Clinical Oncology: Cancer Clinical Trials, 33(5), 448–455. https://doi.org/10.1097/COC.0b013e3181b4b04f

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free